335 related articles for article (PubMed ID: 26456820)
1. Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins.
Wang W; Li N; Li X; Tran MK; Han X; Chen J
Cell Rep; 2015 Oct; 13(3):524-532. PubMed ID: 26456820
[TBL] [Abstract][Full Text] [Related]
2. Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling.
Wang H; Lu B; Castillo J; Zhang Y; Yang Z; McAllister G; Lindeman A; Reece-Hoyes J; Tallarico J; Russ C; Hoffman G; Xu W; Schirle M; Cong F
J Biol Chem; 2016 Jul; 291(29):15256-66. PubMed ID: 27231341
[TBL] [Abstract][Full Text] [Related]
3. The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of angiomotin.
Campbell CI; Samavarchi-Tehrani P; Barrios-Rodiles M; Datti A; Gingras AC; Wrana JL
J Cell Sci; 2016 Sep; 129(18):3396-411. PubMed ID: 27521426
[TBL] [Abstract][Full Text] [Related]
4. Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
Jia J; Qiao Y; Pilo MG; Cigliano A; Liu X; Shao Z; Calvisi DF; Chen X
PLoS One; 2017; 12(9):e0184068. PubMed ID: 28877210
[TBL] [Abstract][Full Text] [Related]
5. Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations.
Troilo A; Benson EK; Esposito D; Garibsingh RA; Reddy EP; Mungamuri SK; Aaronson SA
Oncotarget; 2016 May; 7(20):28765-82. PubMed ID: 27144834
[TBL] [Abstract][Full Text] [Related]
6. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.
Moleirinho S; Hoxha S; Mandati V; Curtale G; Troutman S; Ehmer U; Kissil JL
Elife; 2017 May; 6():. PubMed ID: 28464980
[TBL] [Abstract][Full Text] [Related]
7. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
[TBL] [Abstract][Full Text] [Related]
8. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
[TBL] [Abstract][Full Text] [Related]
9. Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth.
Adler JJ; Heller BL; Bringman LR; Ranahan WP; Cocklin RR; Goebl MG; Oh M; Lim HS; Ingham RJ; Wells CD
J Biol Chem; 2013 May; 288(21):15181-93. PubMed ID: 23564455
[TBL] [Abstract][Full Text] [Related]
10. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
[TBL] [Abstract][Full Text] [Related]
11. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.
Hsu YL; Hung JY; Chou SH; Huang MS; Tsai MJ; Lin YS; Chiang SY; Ho YW; Wu CY; Kuo PL
Oncogene; 2015 Jul; 34(31):4056-68. PubMed ID: 25381822
[TBL] [Abstract][Full Text] [Related]
12. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
Zeng H; Ortiz A; Shen PF; Cheng CJ; Lee YC; Yu G; Lin SC; Creighton CJ; Yu-Lee LY; Lin SH
Oncotarget; 2017 Feb; 8(6):10145-10160. PubMed ID: 28052036
[TBL] [Abstract][Full Text] [Related]
13. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
14. Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer.
Yang J; Zhang X; Chen Z; Shen Y; Wang F; Wang Y; Liu Y; Liu P; Yang J
Cell Death Dis; 2019 Feb; 10(3):179. PubMed ID: 30792381
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling.
Callow MG; Tran H; Phu L; Lau T; Lee J; Sandoval WN; Liu PS; Bheddah S; Tao J; Lill JR; Hongo JA; Davis D; Kirkpatrick DS; Polakis P; Costa M
PLoS One; 2011; 6(7):e22595. PubMed ID: 21799911
[TBL] [Abstract][Full Text] [Related]
16. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation.
Wang C; An J; Zhang P; Xu C; Gao K; Wu D; Wang D; Yu H; Liu JO; Yu L
Biochem J; 2012 Jun; 444(2):279-89. PubMed ID: 22385262
[TBL] [Abstract][Full Text] [Related]
17. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
[TBL] [Abstract][Full Text] [Related]
18. AMOT is required for YAP function in high glucose induced liver malignancy.
Liu Y; Lu Z; Shi Y; Sun F
Biochem Biophys Res Commun; 2018 Jan; 495(1):1555-1561. PubMed ID: 29217192
[TBL] [Abstract][Full Text] [Related]
19. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
[TBL] [Abstract][Full Text] [Related]
20. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
